D2 dissection for gastric cancer

Area of Science:

• Surgical Oncology
• Gastroenterology

Background:

• Gastric cancer remains a significant global health challenge, particularly in certain regions.
• Despite advancements, gastric cancer has a high mortality rate, with limited treatment options historically.
• The Japanese Research Society for Gastric Cancer established lymph node classification and dissection levels (D1-D4).

Purpose of the Study:

• To evaluate the effectiveness of different lymph node dissection levels in gastric cancer surgery.
• To determine the optimal extent of lymphadenectomy for improving patient outcomes.

Main Methods:

• Review of retrospective series comparing D1 and D2 lymph node dissections.
• Analysis of large international trials assessing D1 vs. D2 dissection outcomes.
• Examination of tumor invasion depth and its correlation with lymph node metastasis.

Main Results:

• D2 lymph node dissection is associated with improved staging and survival compared to D1.
• Tumor penetration beyond the serosa (T3) significantly increases the likelihood of N2 lymph node metastasis.
• Trials show comparable morbidity and mortality between D1 and D2 dissections.

Conclusions:

• D2 lymph node dissection is crucial for accurate staging and improved survival in gastric cancer patients.
• Current adjuvant therapies like chemotherapy have not demonstrated reproducible survival benefits.
• Advancements in surgical techniques and anesthesia have improved survival, with D2 dissection being a key factor.